TickerFacts.

OSR Health, Inc. (OSRH): R&D Expense

Annual figures by period end, from SEC filings.

$318.4K
Year ended 2025-12-31
$382.5K
Trailing 12 months to 2026-06-30
2024-12-31: $161.2K2025-12-31: $318.4K$318.4K
2024-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$318.4K+97.6%2026-03-31, From 2025-01-01
2024-12-31$161.2Kn/a2026-03-31, From 2024-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
OSR Health, Inc. (OSRH)2025-12-31$318.4K+97.6%
QHSLab, Inc. (USAQ)2025-12-31$484.9K+64.7%
IceCure Medical Ltd. (ICCM)2025-12-31$7.43M+4.7%
Femasys Inc (FEMY)2025-12-31$7.58M-7.8%
Tenon Medical, Inc. (TNON)2025-12-31$2.15M-17.4%
Vycor Medical Inc (VYCO)2025-12-31$10.0K-35.0%
Lucid Diagnostics Inc. (LUCD)2025-12-31$5.68M-5.2%
Picard Medical, Inc. (PMI)2025-12-31$3.05M-9.8%
Cerenome, Inc. (CNSY)2025-12-31$8.38M-20.8%

Compare OSRH, USAQ, ICCM, FEMY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗